Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Marc Earl"'
Publikováno v:
American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy: AJHP
American Journal of Health-System Pharmacy: AJHP
Purpose A study was conducted to compare an intravenous (IV) gravimetric technology–assisted workflow (TAWF) platform to an IV robotic system. In the study we reviewed both IV technology platforms using the same gravimetric quality assurance system
Autor:
James Blackmer, Heather Zimmer, Jacqueline Amancher, Eric Vogan, Marc Earl, Anthony Boyd, Kevin Amoline, Meave Borton
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(6)
Introduction Many oncology infusions are provided in hospital-based infusion centers. With hospital-based infusion centers seeing increased volumes, patient wait times continue to be a priority. Extended wait times for oncology infusions have been sh
Autor:
Jacqueline L. Olin, Adam Peele, Marc Earl, Jeffrey S. Reichard, Danielle L Roman, Ali McBride, Jason J Bergsbaken
Publikováno v:
American Journal of Health-System Pharmacy. 75:1304-1311
The roles and responsibilities of the pharmacy technician in ambulatory oncology practice have evolved considerably over the past several decades. Historically, technician roles consisted mainly of compounding and technical activities, but technician
Autor:
Caitlin Siebenaller, Hetty E. Carraway, Matt Kalaycio, Simon W. Lam, Marc Earl, Brian I. Rini, Mikkael A. Sekeres, Brian T. Hill, Mandy C. Leonard
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(4)
Introduction As cost of cancer therapy continues to increase, several organizations have developed rubrics to ascertain treatment. No studies have evaluated these methods for hospital formulary decision-making. We applied different value measurement
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:94-103
tudy Objective Gastric cancer is the fifth most common malignancy and second leading cause of cancer-related mortality. Chemotherapy options for patients who fail first-line treatment are limited. Thus the objective of this study was to assess the co
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(21)
Purpose The development and implementation of an operational productivity tool in an academic cancer treatment center are described. Summary Based on the increasing complexity of care delivery within the oncology setting, solutions were explored with
Publikováno v:
Journal of Oncology Pharmacy Practice. 22:625-638
Aim Oncologic emergencies are often categorized as a group of metabolic abnormalities associated with the diagnosis of cancer or the initiation of chemotherapy for treatment. These syndromes often arise in the acute setting, demanding an accurate kno
Autor:
Ran Zhao, Caitlin Siebenaller, Betty K. Hamilton, Bhumika J. Patel, Hetty E. Carraway, Ronald Sobecks, Sudipto Mukherjee, Kelly Gaffney, Matt Kalaycio, Aaron T. Gerds, Anjali S. Advani, Aziz Nazha, Mikkael A. Sekeres, Marc Earl, Marina Feldman, Brian P. Hobbs, Madeline Waldron
Publikováno v:
Blood. 134:3433-3433
Background: Younger patients (pts) with acute myeloid leukemia (AML) who enter a remission after intensive induction chemotherapy routinely receive at least one cycle of consolidation therapy with high dose cytarabine (HiDAC). This is commonly admini
Autor:
Navneet S. Majhail, Matt Kalaycio, Catherine Weber, Brian T. Hill, Lisa Rybicki, Kelley D. Carlstrom, Candice M. Wenzell, J E Lau, Marc Earl
Publikováno v:
Bone Marrow Transplantation. 50:652-657
Obesity continues to be an increasing global health issue contributing to the complexity of chemotherapy dosing in the field of SCT. Investigation into the optimal dosing weight used to calculate chemotherapy doses in obese patients undergoing SCT is
Publikováno v:
The Journal of Community and Supportive Oncology. 13:3-7
Background Cholinergic syndrome is a well established acute adverse reaction associated with irinotecan. Cholinergic side effects can be ameliorated or prevented with anticholinergic agents. To date, no formal studies have compared atropine-diphenoxy